2 patient evaluations for ALS Phase 3 Study TRO19622

Sort by: Most recent

Dec 28, 2011 (Started Nov 17, 2009)

  • Effectiveness
    None (for Participate in clinical trial)
  • Side effects
    None
  • Adherence
    Always
  • Burden
    A little hard to take
Dosage: 1 mg Daily
Cost: < $25 monthly
  • 0 helpful marks

Dec 14, 2011 (Started Feb 25, 2010)

  • Effectiveness
    None (for Participate in clinical trial)
  • Side effects
    None
  • Adherence
    Always
  • Burden
    Not at all hard to take
Dosage: 2 other Daily
Advice & Tips: Pellentesque habitant morbi tristique senectus et netus et malesuada fames ac turpis egestas. Phasellus faucibus turpis sed mi maximus mattis.

Sep 1, 2011 (Started Feb 25, 2010)

  • Effectiveness
    Can't tell (for may slow ALS)
  • Side effects
    None
  • Adherence
    Always
  • Burden
    Not at all hard to take
Dosage: 2 other Daily
Advice & Tips: Pellentesque habitant morbi tristique senectus et netus et malesuada fames ac turpis egestas. Phasellus faucibus turpis sed mi maximus mattis.
  • 0 helpful marks
Last updated:
Showing 2 of 2 patient evaluations for ALS Phase 3 Study TRO19622
See more data on ALS Phase 3 Study TRO19622